The much-anticipated guideline is now available for RQA members.
More information
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationNovember 2025 Edition out now
The U.S. Food and Drug Administration (FDA) has issued draft recommendations clarifying which centre should host “cross-centre” Master Files (MFs) when they support multiple product types.
The Food and Drug Administration (FDA) has published a draft guidance to support the implementation of updated manufacturing rules for medical gases.
The U.S. Food and Drug Administration (FDA) has rolled out “agentic AI” to support staff across the agency — marking a major step in its internal AI rollout.
The International Council for Harmonisation (ICH) held its 2025 Assembly in Singapore, completing major guideline decisions and welcoming new members.
ICH expands its global regulatory network by admitting new members and observers during its November 2025 meeting.
The EMA’s PRAC met 24–27 November to review safety-related issues for authorised medicines — concluding no new referral procedures, but continuing ongoing assessments and routine pharmacovigilance tasks.
A major study offers new insight into how vaccine-derived poliovirus type 2 spreads and what this means for global eradication.
The MHRA sets out new steps to modernise the UK’s medical technology regulatory framework.
The MHRA Inspectorate clarifies updated insurance requirements for Phase 1 clinical trials ahead of the 2026 regulations.